Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Immunoadsorption successfully treated a man's resistant polymyositis.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Ritlecitinib is an effective new treatment for Alopecia Areata.

The drug combination was safe and showed promise in treating advanced tumors.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Hair germ cells differ from epidermal cells in keratin expression, and specific keratins form after hair differentiation.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Thyroid receptor β can help develop new drugs to treat hair loss.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Idiopathic hypoparathyroidism is rare and can be managed with dihydrotachysterol.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

Bioregulatory medicine improved the dog's health and recovery from chemotherapy side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.